Domain-specific models outperform LLMs in pharmacovigilance causal inference

A new study published on arXiv evaluates the effectiveness of different classification models within the InferBERT framework for identifying causal adverse drug events (ADEs) in pharmacovigilance. The research found that domain-specific pre-trained models, such as BioBERT, significantly outperformed larger, general-purpose LLMs like Med-LLaMA and simpler models like XGBoost in accuracy and concordance with traditional pharmacovigilance signals. The study also indicated that while post-hoc calibration can improve model calibration, it has mixed effects on accuracy and causal discovery, suggesting that investing in domain-aware models is more beneficial than simply increasing model size for this application. AI

IMPACT Domain-specific pre-trained models show superior performance over general LLMs for causal inference in pharmacovigilance, guiding future model selection for specialized AI applications.

RANK_REASON Academic paper detailing a comparative analysis of AI models for a specific research task. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.CL →

• ALBERT
• BioBERT
• Med-LLaMA
• XGBoost

• paper
• model release

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →